Prostate-specific antigen glycoprofiling as diagnostic and prognostic biomarker of prostate cancer
Interface Focus · 06.04.2019 · 9 (2) · 20180077
DOI: 10.1098/rsfs.2018.0077 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Interface Focus, online erschienen am 15.02.2019. Verfasst von Jan Tkac und 7 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Chemistry, Slovak Academy of Sciences, Dubravska cesta 9, 84538 Bratislava, Slovakia. Die Arbeit wurde bisher 70-mal zitiert (Crossref) und nennt 74 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: H2020 European Research Council, Agentúra Ministerstva školstva, vedy, výskumu a športu SR, Agentúra na Podporu Výskumu a Vývoja.
Abstract (Originalsprache)
The initial part of this review details the controversy behind the use of a serological level of prostate-specific antigen (PSA) for the diagnostics of prostate cancer (PCa). Novel biomarkers are in demand for PCa diagnostics, outperforming traditional PSA tests. The review provides a detailed and comprehensive summary that PSA glycoprofiling can effectively solve this problem, thereby considerably reducing the number of unnecessary biopsies. In addition, PSA glycoprofiling can serve as a prognostic PCa biomarker to identify PCa patients with an aggressive form of PCa, avoiding unnecessary further treatments which are significantly life altering (incontinence or impotence).
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Institute of Chemistry, Slovak Academy of Sciences, Dubravska cesta 9, 84538 Bratislava, Slovakia.
- Glycanostics Ltd, Dubravska cesta 9, 84538 Bratislava, Slovakia.
- Center for Advanced Materials, Qatar University, Doha 2713, Qatar.
ORCID-Profile: Jan Tkac
Förderung
- H2020 European Research Council
- Agentúra Ministerstva školstva, vedy, výskumu a športu SR
- Agentúra na Podporu Výskumu a Vývoja
- Horizon 2020 Framework Programme
- European Regional Development Fund
Zitieren
APA
Tkac, J., Gajdosova, V., Hroncekova, S., Bertok, T., Hires, M., Jane, E., Lorencova, L., & Kasak, P. (2019). Prostate-specific antigen glycoprofiling as diagnostic and prognostic biomarker of prostate cancer. Interface Focus, 9(2), 20180077. https://doi.org/10.1098/rsfs.2018.0077
Vancouver
Tkac J, Gajdosova V, Hroncekova S, Bertok T, Hires M, Jane E, et al. Prostate-specific antigen glycoprofiling as diagnostic and prognostic biomarker of prostate cancer. Interface Focus. 2019;9(2):20180077. doi:10.1098/rsfs.2018.0077
BibTeX
@article{Tkac2019,
author = {Tkac, Jan and Gajdosova, Veronika and Hroncekova, Stefania and Bertok, Tomas and Hires, Michal and Jane, Eduard and Lorencova, Lenka and Kasak, Peter},
title = {Prostate-specific antigen glycoprofiling as diagnostic and prognostic biomarker of prostate cancer},
journal = {Interface Focus},
year = {2019},
volume = {9},
number = {2},
pages = {20180077},
doi = {10.1098/rsfs.2018.0077}
}
EUVIMED